Pure drug nanoparticles in tablets: what are the dissolution limitations?
暂无分享,去创建一个
[1] J. Varshosaz,et al. Preparation of cefuroxime axetil nanoparticles by rapid expansion of supercritical fluid technology , 2009 .
[2] J. Raper,et al. Dissolution kinetic behavior of drug nanoparticles and their conformity to the diffusion model. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[3] J. Raper,et al. What is a Suitable Dissolution Method for Drug Nanoparticles? , 2008, Pharmaceutical Research.
[4] Y. Choa,et al. Optimization of parameters for the synthesis of zinc oxide nanoparticles by Taguchi robust design method , 2007 .
[5] Jonghwi Lee,et al. Nanoscopic friction behavior of pharmaceutical materials. , 2007, International journal of pharmaceutics.
[6] Alexander T Florence,et al. Pharmaceutical nanotechnology: more than size. Ten topics for research. , 2007, International journal of pharmaceutics.
[7] Filippos Kesisoglou,et al. Application of Nanoparticles in Oral Delivery of Immediate Release Formulations , 2007 .
[8] Vincent Castranova,et al. Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity , 2007 .
[9] Jianfeng Chen,et al. Preparation and Characterization of Amorphous Cefuroxime Axetil Drug Nanoparticles with Novel Technology: High-Gravity Antisolvent Precipitation , 2006 .
[10] Jianfeng Chen,et al. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. , 2006, International journal of pharmaceutics.
[11] Panos Macheras,et al. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. , 2006, International journal of pharmaceutics.
[12] Rainer H. Müller,et al. Drug Nanocrystals/Nanosuspensions for the Delivery of Poorly Soluble Drugs , 2006 .
[13] B. Leclerc,et al. Compaction behaviour and new predictive approach to the compressibility of binary mixtures of pharmaceutical excipients. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[14] A F Thünemann,et al. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals. , 2006, International journal of pharmaceutics.
[15] Ernesto Reverchon,et al. Nanomaterials and supercritical fluids , 2006 .
[16] Uday B. Kompella,et al. Nanoparticle technology for drug delivery , 2006 .
[17] Ram B. Gupta,et al. Fundamentals of Drug Nanoparticles , 2006 .
[18] L. Augsburger,et al. Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution , 2005, AAPS PharmSciTech.
[19] E. Sacher,et al. Surface diffusion and coalescence of mobile metal nanoparticles. , 2005, The journal of physical chemistry. B.
[20] G Vergnault,et al. Nanosuspension Formulations for Low-Soluble Drugs: Pharmacokinetic Evaluation Using Spironolactone as Model Compound , 2005, Drug development and industrial pharmacy.
[21] Vandana B. Patravale,et al. Current strategies for engineering drug nanoparticles , 2004 .
[22] Ho-Cheol Kim,et al. Nanoscale effects leading to non-Einstein-like decrease in viscosity , 2003, Nature materials.
[23] Jonghwi Lee. Drug nano- and microparticles processed into solid dosage forms: physical properties. , 2003, Journal of pharmaceutical sciences.
[24] Robert K. Prud'homme,et al. Chemical Processing and Micromixing in Confined Impinging Jets , 2003 .
[25] M. López-Quintela,et al. Synthesis of nanomaterials in microemulsions: formation mechanisms and growth control ☆ , 2003 .
[26] E. Kauppinen,et al. Aerosol flow reactor method for synthesis of drug nanoparticles. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[27] D. Flanagan,et al. General solution for diffusion-controlled dissolution of spherical particles. 2. Evaluation of experimental data. , 2002, Journal of pharmaceutical sciences.
[28] L. Bartell,et al. Structure and properties of potassium iodide nanoparticles. A molecular dynamics study , 2001 .
[29] D. F. Steele,et al. Directional Bonding in Compacted Microcrystalline Cellulose , 2001, Drug development and industrial pharmacy.
[30] D. F. Steele,et al. The mechanical properties of compacts of microcrystalline cellulose and silicified microcrystalline cellulose. , 2000, International journal of pharmaceutics.
[31] D. Flanagan,et al. General solution for diffusion-controlled dissolution of spherical particles. 1. Theory. , 1999, Journal of pharmaceutical sciences.
[32] K. Imada,et al. Morphological effect of microcrystalline cellulose particles on tablet tensile strength. , 1999, International journal of pharmaceutics.
[33] D. Storey,et al. Design and characterization of a surfactant-enriched tablet formulation for oral delivery of a poorly water-soluble immunosuppressive agent. , 1999, International journal of pharmaceutics.
[34] P. Stewart,et al. Deaggregation during the dissolution of benzodiazepines in interactive mixtures. , 1998, Journal of pharmaceutical sciences.
[35] H. Larhrib,et al. Compression of thermally treated Polyethylene glycol 10,000 , 1997 .
[36] A. Fassihi. Mechanisms of disintegration and compactibility of disintegrants in a direct compression system , 1986 .
[37] Genichii Taguchi,et al. Introduction to quality engineering. designing quality into products a , 1986 .
[38] A. P. Ball,et al. Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection. , 1985, The Journal of antimicrobial chemotherapy.
[39] Alexander T. Florence,et al. Surfactant Systems: Their chemistry, pharmacy and biology , 1983 .
[40] N. Pilpel,et al. Formulation factors affecting strength and dissolution of uncoated oxytetracycline tablets. , 1977, Journal of pharmaceutical sciences.
[41] L. Augsburger,et al. Flexure test for determination of tablet tensile strength. , 1974, Journal of pharmaceutical sciences.
[42] J. Newton,et al. Determination of tablet strength by the diametral-compression test. , 1970, Journal of pharmaceutical sciences.
[43] A. Aguiar,et al. Deaggregation behavior of a relatively insoluble substituted benzoic acid and its sodium salt. , 1967, Journal of pharmaceutical sciences.
[44] Linda M. Katz,et al. Nanotechnology and applications in cosmetics : General overview , 2007 .
[45] Franz Konstantin Fuss,et al. Application of Taguchi method in optimization of cervical ring cage. , 2007, Journal of biomechanics.
[46] G. Alderborn. Tablets and compaction , 2007 .
[47] Christos Reppas,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.
[48] Robert A. Reed,et al. Acceptable Analytical Practices for Dissolution Testing of Poorly Soluble Compounds , 2004 .
[49] M. H. El-Shabouri. Nanoparticles for improving the dissolution and oral bioavailability of spironolactone, a poorly-soluble drug , 2002 .
[50] I. Kanfer. Report on the International Workshop on the Biopharmaceutics Classification System (BCS): scientific and regulatory aspects in practice. , 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[51] Giovanni Filippo Palmieri,et al. Evaluation of Ethylcellulose-Coated Pellets Optimized Using the Approach of Taguchi , 1997 .
[52] A. Stamm,et al. Tablet Formulation : Genichi Taguchi's Approach , 1993 .
[53] R. Dempski,et al. Simultaneous Optimization of Capsule and Tablet Formulation Using Response Surface Methodology , 1993 .
[54] P. Rue,et al. Work Required to Cause Failure of Tablets in Diametral Compression , 1978 .